Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Recurso Textual
|
![]() |
|
2 |
Material Type: Recurso Textual
|
![]() |
|
3 |
Material Type: Recurso Textual
|
![]() |
|
4 |
Material Type: Recurso Textual
|
![]() |
|
5 |
Material Type: Recurso Textual
|
![]() |
|
6 |
Material Type: Recurso Textual
|
![]() |
|
7 |
Material Type: Recurso Textual
|
![]() |
|
8 |
Material Type: Dataset
|
![]() |
An investigator-initiated, non-randomised, phase II study of combination CTLA-4 and PD-L1 blockade in combination with HER2 blockade in advanced HER2-positive breast cancers that have progressed on prior trastuzumab-based therapy (BCT 1703 DIAmOND)Loi, Sherene ; Breast Cancer Trials (BCT)Breast Cancer Trials (BCT) 2026Texto completo disponível |
9 |
Material Type: Recurso Textual
|
![]() |
|
10 |
Material Type: Recurso Textual
|
![]() |
|